Leading your next capital markets transaction
Public and private financial institutions, including banks, bank holding companies and investment banks, as well as healthcare companies, including clinical trial and medical device companies, rely upon Wes Scott’s experience, judgment and business acumen to close their capital market transactions. Wes has quarterbacked numerous initial public offerings, primary and secondary follow-on offerings, mergers, acquisitions, dispositions, joint ventures and other transformative transactions. Wes leads the firm’s Banking and Investments initiative.
Wes regularly assists these companies and their boards of directors and special committees with the following:
- Public and private offerings of equity and debt securities;
- SEC, FINRA and FDIC reporting compliance;
- Stock exchange listing compliance;
- Mergers and acquisitions;
- Strategic planning and executive succession;
- Recapitalizations and restructurings;
- Corporate governance best practices; and
- General corporate matters.
His recent experience related to financial institutions includes providing counsel to:
- Multiple community banks with respect to their ongoing legal and operational needs
- An NYSE-listed bank in a private placement of $100 million of Subordinated Notes
- An NYSE-listed bank in public offerings of $300 million of Subordinated Notes and $172.5 million of Preferred Stock
- An NYSE-listed bank in multiple bank acquisitions involving aggregate proceeds in excess of $650 million
- An NYSE-listed bank in a merger involving aggregate proceeds of approximately $50 million and a multi-branch acquisition valued at approximately $37 million
- A NASDAQ-listed bank in connection with exit of its primary institutional investor through block trades and privately-negotiated transactions involving interrelated federal securities laws
- An NYSE-listed bank in secondary sale of common stock involving aggregate proceeds of approximately $152 million
- A NASDAQ-listed bank in connection with its IPO involving aggregate proceeds of approximately $45 million
His recent experience related to healthcare companies includes providing counsel to:
- Multiple clinical trial and research companies in their sales to strategic acquirers involving aggregate proceeds of approximately $100 million
- Numerous emerging growth medical device companies in obtaining debt and equity capital through angel investors and venture capital and private equity funds
- A strategic acquirer in its acquisition of a behavioral health hospital involving aggregate proceeds of approximately $100 million
- Multiple emergency medicine physician practice groups involving aggregate proceeds of approximately $325 million
Wes is a frequent contributor to Waller's Capital Markets and Securities Blog and has been published on TheCorporateCounsel.net and quoted in BankDirector.com and Accounting Today.
Wes is recognized by Best Lawyers for Corporate Governance Law and Mergers & Acquisitions Law.